NCT03731741View on ClinicalTrials.gov

Does Oral Pentoxifylline Administration Improve Hemoglobin in Hemodialysis Patients?

PHASE2CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

May 3, 2018

Study Completion Date

May 4, 2018

Conditions
Anemia of Chronic Kidney Disease
Interventions
DRUG

Pentoxifylline

a known drug of xanthine derivatives used in intermittent claudication

Trial Locations (1)

Unknown

Tanta university hospital, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT03731741 - Does Oral Pentoxifylline Administration Improve Hemoglobin in Hemodialysis Patients? | Biotech Hunter | Biotech Hunter